Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

New England Journal of Medicine Publishes Positive Phase 3 Trial Results for REGEN-COV (casirivimab and imdevimab) to Prevent SARS-CoV-2 Infection

firstwordpharmaAugust 05, 2021

Tag: REGEN-COV , SARS-CoV-2 , COVID-19

PharmaSources Customer Service